Solesence, Inc. (SLSN) Income Statement
SLSN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSLSN revenue and net income
Where SLSN's revenue goes
2025Each bar shows an amount and its share of revenue. SLSN kept 2.9% of revenue as net income.
SLSN profit margins
SLSN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +18.6% | +18.5% | — | — |
| Gross profit | −1.0% | +24.2% | — | — |
| Operating income | −69.4% | — | — | — |
| Net income | −57.7% | — | — | — |
| EPS (diluted) | −50.0% | +44.2% | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SLSN quarterly EPS vs estimates
Next report: November 10, 2026.
SLSN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | $29.5M |
| Cost of revenue | $46.0M | $36.2M | $29.5M | $29.0M | $20.8M |
| Gross profit | $16.0M | $16.2M | $7.8M | $8.4M | $8.7M |
| Research & development | $4.1M | $3.8M | $3.8M | $3.0M | $2.2M |
| Sales, general & admin | $10.4M | $7.2M | $7.5M | $7.6M | $3.9M |
| Total operating expenses | $14.5M | $11.1M | $11.4M | $10.6M | $6.1M |
| Operating income | $1.6M | $5.1M | −$3.5M | −$2.3M | $2.6M |
| Interest expense | $931,000 | $670,000 | $838,000 | $382,000 | $1.2M |
| Income before taxes | $1.9M | $4.5M | −$4.4M | −$2.6M | $2.4M |
| Income taxes | $73,000 | $227,000 | $6,000 | −$17,000 | $37,000 |
| Net income | $1.8M | $4.2M | −$4.4M | −$2.6M | $2.3M |
| EBITDA | $3.7M | $6.1M | −$2.8M | −$1.7M | $4.0M |
| EPS (diluted) | $0.03 | $0.06 | −$0.09 | $0.01 | $0.05 |
| Gross margin | 25.8% | 30.9% | 21.0% | 22.4% | 29.5% |
| Operating margin | 2.5% | 9.8% | −9.5% | −6.1% | 8.7% |
| Net margin | 2.9% | 8.1% | −11.8% | −7.0% | 7.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.3M | $13.0M | $12.5M | $14.6M | $20.4M | $14.6M | $12.6M | $16.9M | $13.0M | $9.9M | $8.0M |
| Cost of revenue | $10.6M | $9.6M | $9.1M | $11.2M | $14.5M | $11.2M | $9.8M | $10.8M | $9.3M | $6.3M | $7.5M |
| Gross profit | $4.7M | $3.3M | $3.4M | $3.4M | $5.9M | $3.4M | $2.8M | $6.1M | $3.7M | $3.6M | $471,000 |
| Research & development | $947,000 | $1.0M | $1.0M | $1.1M | $955,000 | $1.0M | $1.1M | $970,000 | $864,000 | $910,000 | $785,000 |
| Sales, general & admin | $3.7M | $2.8M | $2.2M | $3.1M | $3.0M | $2.1M | $1.9M | $1.9M | $1.8M | $1.6M | $1.6M |
| Total operating expenses | $4.6M | $3.8M | $3.2M | $4.2M | $4.0M | $3.1M | $3.0M | $2.9M | $2.7M | $2.5M | $2.4M |
| Operating income | $121,000 | −$504,000 | $186,000 | −$781,000 | $1.9M | $256,000 | −$223,000 | $3.2M | $1.0M | $1.1M | −$1.9M |
| Interest expense | $279,000 | $263,000 | $328,000 | $339,000 | $87,000 | $176,000 | $108,000 | $153,000 | $191,000 | $218,000 | $225,000 |
| Income before taxes | −$158,000 | −$766,000 | −$154,000 | −$1.1M | $3.1M | $80,000 | −$331,000 | $3.0M | $856,000 | $893,000 | −$2.1M |
| Income taxes | — | — | −$317,000 | — | $390,000 | — | $227,000 | — | — | — | $6,000 |
| Net income | −$158,000 | −$766,000 | $163,000 | −$1.1M | $2.7M | $80,000 | −$558,000 | $3.0M | $856,000 | $893,000 | −$2.1M |
| EBITDA | $444,000 | −$190,000 | $395,000 | −$556,000 | $3.4M | $482,000 | $5,000 | $3.4M | $1.3M | $1.3M | −$1.7M |
| EPS (diluted) | $0.04 | −$0.01 | $0.00 | −$0.02 | $0.04 | $0.00 | −$0.01 | $0.04 | $0.01 | $0.02 | −$0.04 |
| Gross margin | 31.0% | 25.7% | 27.4% | 23.1% | 28.9% | 23.1% | 22.0% | 36.2% | 28.7% | 36.3% | 5.9% |
| Operating margin | 0.8% | −3.9% | 1.5% | −5.4% | 9.4% | 1.8% | −1.8% | 19.0% | 8.0% | 11.3% | −23.7% |
| Net margin | −1.0% | −5.9% | 1.3% | −7.7% | 13.1% | 0.5% | −4.4% | 18.1% | 6.6% | 9.0% | −26.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SLSN's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SLSN financial results
In fiscal year 2025 (ended December 31, 2025), Solesence reported revenue of $62.1 million, up 18.6% from the year before. It had net income of $1.8 million (down 57.7%), a net profit margin of 2.9%. Diluted earnings per share came to $0.03.
See the SLSN stock overview for the latest quote and news, or the SLSN chart for price history and technical indicators.
SLSN income statement FAQ
What is Solesence's annual revenue?
Solesence reported total revenue of $62.1 million for fiscal year 2025, which ended on December 31, 2025. That was up 18.6% from $52.3 million the previous year.
Is Solesence profitable?
Yes. Solesence reported net income of $1.8 million in fiscal 2025, a net profit margin of 2.9%; its operating margin was 2.5%.
What is Solesence's gross margin?
Solesence's gross margin was 25.8% in fiscal 2025: for every $100 of revenue, Solesence kept $26 after the direct cost of its products and services.
How much does Solesence spend on research and development?
Solesence spent $4.1 million on research and development in fiscal 2025, 6.6% of revenue.
What are Solesence's earnings per share?
Solesence earned $0.03 per diluted share in fiscal 2025, compared with $0.06 a year earlier.
When will Solesence report its next earnings?
Solesence is expected to report results for the quarter ending September 30, 2026 on November 10, 2026.
When does Solesence's fiscal year end?
Solesence's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 31, 2026.